Latest Industry Projects

Kaneka Eurogentec Plans to Construct New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility in Belgium

Kaneka Eurogentec Plans to Construct New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility in Belgium

Introduction:

Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO) announced the construction of a new state of-the-art GMP facility.

Features:

The expansion will allow for the large scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA.

The multi-product facility will include the capability for large scale production using innovative Eurogentec technologies such as the improved production of complex proteins by secretion from yeasts and the production of kilo-scale plasmid DNA for viral and non-viral gene and cell therapies. This expansion will be complementary to the current capabilities and together will provide small and industrial scale production.

The state-of-the-art facility will be equipped for the production and purification of new biomedicines using cost-effective and safe microbial strains and will include the installation of a 2200 L fermenter, harvest and purification equipment for all expression strategies.

Construction is expected to start in autumn of 2017. Additionally, the expansion will result in the hiring of 40 full time scientific staff trained in the production of GMP therapeutic products.

Specifications:

Name Kaneka Eurogentec
Location Belgium
Type Pharmaceutical Grade Biologics Manufacturing Facility
Construction Starts In Autumn of 2017

 

Source: businesswire.com

Other Projects